Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FDA Highlights Hands-On Approach To China Inspections In Budget Plan

Executive Summary

The inspection focus of the budget request is largely on adding more personnel, but the agency continues to think about how best to target and leverage its resources in its globalization plan.

You may also be interested in...



How FDA Plans To Stop Worrying And Love Globalization

New deputy commissioner Howard Sklamberg tells “The Pink Sheet” that globalization of the drug supply eventually will become more commonplace, and ideally less of a concern, for American consumers.

FDA Closing Office In Jordan To Better Leverage Shrinking Resources

Opened as part of the globalization initiative, FDA’s presence in the Middle East and North Africa will shut down in late December in an apparent cost-cutting effort.

FDA Closing Office In Jordan To Better Leverage Shrinking Resources

Opened as part of the globalization initiative, FDA’s presence in the Middle East and North Africa will shut down in late December in an apparent cost-cutting effort.

Related Content

Topics

UsernamePublicRestriction

Register

OM008605

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel